Clinical Research Directory
Browse clinical research sites, groups, and studies.
Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia
Sponsor: China Medical University Hospital
Summary
Previous studies found that some NMDA-enhancing agents were able to improve clinical symptoms of patients with schizophrenia. In addition, several drugs with antioxidant properties have been tested in clinical trials for the treatment of schizophrenia too. Whether combined treatment of an NMDA-enhancing agent and a drug with antioxidant property can be better than an NMDA-enhancing agent alone deserves study.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2020-11-30
Completion Date
2027-03
Last Updated
2025-02-19
Healthy Volunteers
No
Conditions
Interventions
NMDAE plus AO
Use of an NMDA enhancer plus a drug with antioxidant property for the treatment of schizophrenia.
NMDAE plus Placebo Cap
Use of an NMDA enhancer plus placebo as a comparator.
Locations (1)
Department of Psychiatry, China Medical University Hospital
Taichung, Taiwan